Squamous Cell Carcinoma of the Head and Neck (SCCHN)
1 competing product in clinical development for Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Pipeline by Phase
Phase 1/21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| avelumab + Bempegaldesleukin + talazoparib + enzalutamide | Astellas Pharma | Phase 1/2 | Terminated | 24 |